Keeping up with medical news when you have brain fog is exhausting. It is even harder when the internet is full of sensationalised headlines announcing a new ‘miracle cure’, or clinics charging large sums for unproven treatments.

This page is not a feed of the latest headlines. It is a guide to where reliable ME/CFS news actually lives, and how to read it without burning through the limited energy you have.

Most health news coverage of ME/CFS is poor. Stories are often oversimplified, overclaimed, or drawn from preliminary research that has not yet been replicated.

Before giving a story your attention, it is worth checking a few things:

How is the story framed? Responsible coverage talks about ‘findings’, ‘associations’, ‘possible mechanisms’, or ‘early evidence’. Be cautious of language like ‘breakthrough’, ‘miracle’, or ‘cure’.

Who funded the research? Reliable studies are usually funded by universities, major research charities, or public research councils. Be wary of work funded only by a clinic or company that sells the treatment being promoted.

Has the research been peer-reviewed and published? Press releases about findings that have not yet been peer-reviewed — or that have only been presented at a conference — should be read as provisional.

Is it a single study, or part of a broader pattern? Individual studies often contradict each other. Reliable reporting puts new findings in the context of what else is known.

The ‘cure’ red flag

Be very sceptical of any article or clinic claiming a 100% cure for ME/CFS. Real scientific progress usually happens in small steps. Reliable organisations will talk about ‘treatments’, ‘symptom management’, or ‘biomarkers’ rather than overnight cures.

If a headline sounds too good to be true, check who funded the research. Trustworthy news usually comes from major universities, established patient advocacy groups, or recognised medical journals.

You do not need to read specialist journals to stay informed. A small number of established organisations summarise new research in accessible language and apply appropriate caution to their reporting.

Research and science updates

Open Medicine Foundation (OMF). Funds ME/CFS research centres globally and publishes plain-language updates on its work.

ME Research UK. A UK charity funding biomedical ME/CFS research, with summaries of published studies aimed at a general audience.

Solve M.E. A US organisation focused on research and advocacy for ME/CFS and Long Covid, offering webinars and newsletters.

Advocacy and policy updates

MEAction. A patient-led advocacy network tracking scientific and political developments globally.

Action for ME. A UK charity covering welfare, policy, and patient support alongside research news.

ME Association. Publishes medically reviewed factsheets and regular updates on UK-specific developments.

Even good reporting can make a study sound more conclusive than it is.

• A single study is not proof. Findings need to be replicated — ideally by other teams, in other populations — before they can be considered reliable.
• Correlation is not causation. A study finding that people with ME/CFS differ from healthy controls in some way does not mean that difference caused the illness.
• Preliminary is the most important word in research news. Early findings are the starting point of a long process. Most do not hold up.

If a claim sounds too good to be true, it almost always is. A treatment that genuinely resolved ME/CFS would not be announced through a tabloid headline or a private clinic’s marketing material.

Following chronic illness news can feel heavy — particularly when progress seems slow, or when a long-awaited trial returns inconclusive results. It is reasonable to step away from the news cycle.

The scientific progress being made will still be there when you have the energy to check back. Focus on your pacing, your own management, and the people in your life. The news can wait.